Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 232

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 232
---
 of Common Stock 1,949,317 Pre-Funded Warrants to Purchase up to 1,949,317Shares of Common Stock and up to 1,949,317 Shares of Common Stock Underlying the Pre-Funded Warrants Up to 7,797,268 Class H Common Stock Warrants to Purchase up to 7,797,268 Shares of Common Stock and up to 7,797,268 Shares of Common Stock Underlying the Class H Common Stock Warrants PRELIMINARY PROSPECTUS Roth Capital Partners May , 2025 PART II. INFORMATION NOT REQUIRED IN PROSPECTUS Item 13. Other Expenses of Issuance and Distribution. The estimated expenses of the offering (assuming all shares are sold), all of which are to be paid by the Registrant, are as follows:

|                              |     | Amount |         |
|:-----------------------------|:----|:-------|--------:|
| SEC Registration Fee         |     | $      |   4,593 |
| Printing Expenses            |     |        |  25,000 |
| Accounting Fees and Expenses |     |        |  70,000 |
| Legal Fees and Expenses      |     |        | 165,000 |
| TOTAL                        |     | $      | 264,593 |

Item 14. Indemnification of Directors and Officers. As permitted by Section 102 of the Delaware General Corporation Law, we have adopted provisions in our Charter and amended and restated bylaws that limit or eliminate the personal liability of our directors for a breach of their fiduciary duty of care as a director. The duty of care generally requires that, when acting on behalf of the corporation, directors exercise an informed business judgment based on all material information reasonably available to them. Consequently, a director will not be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except for liability for:

| ● | any breach of the director’s duty of loyalty to us 
 or our stockholders;                               |

| ● | any act or omission not in good faith or that involves intentional 
 misconduct or a knowing violation of law;                          |

| ● | any act related to unlawful stock repurchases, redemptions 
 or other distributions or payment of dividends; or         |

| ● | any transaction from which the director derived an improper 
 personal benefit.                                           |

These limitations of liability do not affect the availability of equitable remedies such as injunctive relief or